A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer.

A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer. Ann Surg. 2013 Dec; 258(6):879-86.

View in: PubMed

subject areas

Adult
Aged
Cancer Vaccines
Carcinoembryonic Antigen
Colorectal Neoplasms
Dendritic Cells
Disease-Free Survival
Female
Granulocyte-Macrophage Colony-Stimulating Factor
Humans
Immunization
Male
Membrane Glycoproteins
Middle Aged
Mucin-1
Neoplasm Metastasis
Neoplasm Recurrence, Local
Poxviridae

authors with profiles

David J. Cole